Cargando…
Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer’s disease: possible mechanisms of IDE in T2D and AD
Insulin degrading enzyme (IDE) is believed to act as a junction point of Type 2 diabetes (T2D) and Alzheimer's disease (AD); however, the underlying mechanism was not completely clear yet. Transgenic APPSwe/PS1 mice were used as the AD model and were treated with streptozocin/streptozotocin (ST...
Autores principales: | Li, Huajie, Wu, Jian, Zhu, Linfeng, Sha, Luolin, Yang, Song, Wei, Jiang, Ji, Lei, Tang, Xiaochun, Mao, Keshi, Cao, Liping, Wei, Ning, Xie, Wei, Yang, Zhilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435468/ https://www.ncbi.nlm.nih.gov/pubmed/29222348 http://dx.doi.org/10.1042/BSR20170862 |
Ejemplares similares
-
Concordant Association of Insulin Degrading Enzyme Gene (IDE) Variants with IDE mRNA, Aß, and Alzheimer's Disease
por: Carrasquillo, Minerva M., et al.
Publicado: (2010) -
Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging
por: Corraliza-Gomez, Miriam, et al.
Publicado: (2023) -
A Monomeric Variant of Insulin Degrading Enzyme (IDE) Loses Its Regulatory Properties
por: Song, Eun Suk, et al.
Publicado: (2010) -
Insulin-Degrading Enzyme: Paradoxes and Possibilities
por: Leissring, Malcolm A.
Publicado: (2021) -
Extensive substrate recognition by the streptococcal antibody-degrading enzymes IdeS and EndoS
por: Sudol, Abigail S. L., et al.
Publicado: (2022)